Metacrine Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 39
Employees
  • Stock Symbol
  • MTCR
Stock Symbol
  • Share Price
  • $3.97
  • (As of Friday Closing)

Metacrine General Information

Description

Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 3985 Sorrento Valley Boulevard
  • Suite C
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Metacrine Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Metacrine Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.97 $4.25 $3.30 - $16.19 $105M 26.4M 179K $22.93

Metacrine Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 76,055 106,008
Revenue 0 0 0 1,450
EBITDA (42,304) (35,855) (29,174) (25,926)
Net Income (43,960) (37,304) (28,933) (25,821)
Total Assets 92,684 104,236 60,281 77,804
Total Debt 11,006 11,120 11,447 2,853
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Metacrine Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Metacrine‘s full profile, request access.

Request a free trial

Metacrine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Metacrine‘s full profile, request access.

Request a free trial

Metacrine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapi
Pharmaceuticals
San Diego, CA
39 As of 2021
00000
0000 0000-00-00
00000000 00000

00000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
New York, NY
000 As of 0000
00000
000000 - 000 00000

0000 000

nt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
000000000000000
Newton, MA
00 As of 0000
0000
000000 - 000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Metacrine Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intercept(Biotechnology) Formerly VC-backed New York, NY 000 00000 000000 - 000 00000
0000 000000000000 Formerly VC-backed Newton, MA 00 0000 000000 - 000 0000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000 00000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
You’re viewing 5 of 22 competitors. Get the full list »

Metacrine Executive Team (14)

Name Title Board Seat Contact Info
Trisha Millican Chief Financial Officer
Kathie Huynh Executive
Catherine Lee Executive Vice President & General Counsel, Legal
Nicholas Smith Ph.D Senior Vice President, Chemistry
Karl Cremer Vice President, Clinical Operations
You’re viewing 5 of 14 executive team members. Get the full list »

Metacrine Board Members (10)

Name Representing Role Since
Amir Nashat Ph.D Polaris Partners Board Member 000 0000
Andrew Guggenhime Self Board Member 000 0000
John McHutchison MD Self Board Member 000 0000
Julia Owens Ph.D Self Board Member 000 0000
Kristina Burow ARCH Venture Partners Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Metacrine Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Metacrine Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Metacrine‘s full profile, request access.

Request a free trial